What Factors Propelled The Growth Of The Bioprocess Technology Market In The Past?
The bioprocess technology market has seen considerable growth due to a variety of factors.
• The expansion of the bioprocess technology market has been significant in recent years, with predictions estimating an increase from $25.08 billion in 2024 to $29.01 billion in 2025, embodying a compound annual growth rate (CAGR) of 15.7%. This growth during the historic period is credited to the expansion of the biopharmaceutical industry, a rise in chronic diseases, supportive regulations, an increase in research and development activities, along with the globalization of biopharmaceutical production.
What Are the Future Growth Projections for the Bioprocess Technology Market in the Coming Years?
The Bioprocess Technology market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to experience a swift expansion in the coming years, the market size for bioprocess technology is projected to reach $52.94 billion in 2029, with a compound annual growth rate (CAGR) of 16.2%.
The substantial growth during the prognosis period can be credited to factors such as the advent of single-use bioprocessing, cell and gene therapies, bioprocessing for environmental-friendly practices, and an increasing tendency to outsource bioprocessing services, as well as global readiness for pandemics. Salient trends during the forecast period encompass single-use bioprocessing, continuous bioprocessing, the advancement in analytics and process monitoring, personalized medicinal and cell therapies, strategic alliances and partnerships, along with gene editing technologies.
What Are The Core Factors Supporting Growth In The Bioprocess Technology Market?
The bioprocess technology market is projected to experience growth, driven by the increasing demand from healthcare industries. These industries comprise firms or institutions that offer medical-related products, services, and technologies. Bioprocess technology involves the use of living cells, including bacterial or mammalian cells, for the production of therapeutic proteins, vaccines, and other biologics. These play an essential role in the production of biopharmaceuticals and various healthcare products. For example, in 2022 as per the Office for National Statistics, a national statistics organization based in the UK, the healthcare expenditure in the UK touched nearly $354.88 billion (£283 billion), marking a nominal rise of 0.7% from the expenditure in 2021. This rising demand from the healthcare sectors is hence fuelling the expansion of the bioprocess technology market.
What Are The Major Segments Within The Global Bioprocess Technology Market?
The bioprocess technology market covered in this report is segmented –
1) By Type: Cell Culture, Cell Expansion, Flow Cytometry, Cell Line Development, Virus Infiltration
2) By Application: Biopharmaceuticals, Specialty Products, Industry Chemicals, Environment Management Aid
3) By End User: Hospitals, Research labs, Medical Institutions, Other End Users
Subsegments:
1) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture
2) By Cell Expansion: Adherent Cell Expansion, Suspension Cell Expansion
3) By Flow Cytometry: Cell Analysis, Cell Sorting
4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development
5) By Virus Infiltration: Viral Vector Production, Virus Filtration Techniques
Pre-Book The Bioprocess Technology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Bioprocess Technology Market?
Key businesses in the bioprocess technology sector are focusing on bringing forth technologically advanced products like Livit Flex to maintain their competitive edge in the market. Livit Flex, an innovative bioprocessing control system, is specifically designed to speed up research and development (R&D) process for pharmaceuticals and biotech products. The breakthrough product was introduced by Getinge, a Sweden-based healthcare enterprise in December 2022. The attributes of Livit Flex like flexibility, customizability, simplicity, as well as time and cost-efficiency enhance the overall process optimization. The system boasts of smart sensor technology and user-friendly software capabilities. It enables users to swiftly initiate parallel experiments and supervise all data from a unified location. Livit Flex can either be set up as a single or dual control system for single-use or multiple-use bioreactors, optimizing the available bench space in labs.
Who Are the Key Players In The Bioprocess Technology Market?
Major companies operating in the bioprocess technology market include:
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Lonza Group AG
• F. Hoffmann-La Roche Ltd.
• Becton Dickinson and Company
• Merck KGa
• GE Healthcare
• Eppendorf AG
• Bio-Rad Laboratories
• Alere Inc.
• Fujifilm Healthcare Americas Corporation
• Catalent Inc.
• Asahi Kasei Medical America Inc.
• Advanced Instruments LLC
• Nova Biomedical Corporation
• MilliporeSigma
• Repligen Corporation
• Danaher Corporation
• PerkinElmer Inc.
• Applikon Biotechnology
• New Brunswick Scientific Co. Inc.
• Avid Bioservices
• ZETA Holding GmbH
• Meissner Filtration Products
• ABL Europe
• ARTeSYN Biosolutions
• Charles River Laboratories
• Parker Hannifin Corporation
• Shimadzu Corporation
• 3M
• Eppendorf Biochip Systems
• Fermenter Bioreactor
• YMC Europe GmbH
• Solaris Biotechnology Srl
• Aber Instruments
• Cytiva
What Is The Most Dominant Region In The Bioprocess Technology Market?
North America was the largest region in the bioprocess technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the bioprocess technology market report during the forecast period. The regions covered in the bioprocess technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
